Salix Coronary Plaque vs FEops HEARTguideTM

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Salix Coronary Plaque

by Artrya Limited

FEops HEARTguideTM

by FEops nv

AI Verdict

Tool A, Salix Coronary Plaque, is primarily a diagnostic tool for assessing coronary artery disease through plaque and stenosis analysis from CCTA scans. In contrast, Tool B, FEops HEARTguideTM, is a procedural planning platform for structural heart interventions, using predictive simulations to optimize device sizing and positioning. While both are cloud-based Cardiology AI tools leveraging CT data, their distinct applications mean they serve different clinical needs within cardiac care.

Choose Salix Coronary Plaque if…

Choose Salix Coronary Plaque if your primary need is rapid, AI-driven analysis of CCTA scans for the early detection and quantification of coronary artery plaque and stenosis. This tool is ideal for clinicians seeking near real-time, point-of-care insights to diagnose coronary artery disease, assess plaque characteristics, and stratify patient risk efficiently.

View Salix Coronary Plaque →

Choose FEops HEARTguideTM if…

Choose FEops HEARTguideTM if you require advanced predictive simulations and detailed anatomical insights for planning complex structural heart interventions like TAVI or LAAO. This platform is best suited for optimizing device sizing and positioning, leveraging digital twin technology to enhance procedural success and minimize complications.

View FEops HEARTguideTM →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Salix Coronary Plaque	FEops HEARTguideTM
Pricing	Contact for pricing	Contact for pricing
Deployment	Cloud	Cloud-based
FDA Status	Yes AI-estimated	1 AI-estimated

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Salix Coronary Plaque	FEops HEARTguideTM
Product Name	Salix Coronary Plaque	FEops HEARTguideTM
Company	Artrya Limited	FEops nv
Description	FDA-cleared, AI-driven, web-based software that provides near real-time, point-of-care assessment of coronary artery plaque and stenosis from CCTA scans, aiding in the rapid and accurate diagnosis of coronary artery disease.	Cloud-based AI and digital twin platform for structural heart procedure planning, providing predictive simulations and anatomical insights to optimize device sizing and positioning for interventions like TAVI and LAAO.
Key Functionality	AI-enabled CCTA analysis, near real-time, point-of-care assessment, detection and quantification of coronary plaque and stenosis, identification of high-risk plaque features, quantification of calcifications.	Predictive simulation technology for device-anatomy interaction, AI-based anatomical measurements from CT scans, segmentation of cardiovascular structures, visualization and image reconstruction.
Specialties	Cardiology, Radiology	Cardiology, Cardiothoracic Surgery, Radiology

Videos

Demos, reviews, and walkthroughs featuring Salix Coronary Plaque and FEops HEARTguideTM.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What are the primary clinical applications of Salix Coronary Plaque compared to FEops HEARTguideTM?

Salix Coronary Plaque is designed for the near real-time, point-of-care assessment of coronary artery plaque and stenosis from CCTA scans, aiding in the rapid and accurate diagnosis of coronary artery disease. In contrast, FEops HEARTguideTM is a platform for structural heart procedure planning, providing predictive simulations and anatomical insights to optimize device sizing and positioning for interventions like TAVI and LAAO.

How do the operational workflows differ between Salix Coronary Plaque and FEops HEARTguideTM?

Salix Coronary Plaque offers near real-time, point-of-care assessment with integrated workflow management and automated report generation. FEops HEARTguideTM operates on a service-based business model where clinicians provide input data, FEops prepares the analysis, and then delivers the results.

What specific types of insights or measurements do these tools provide?

Salix Coronary Plaque provides detection and quantification of coronary plaque, identification of high-risk plaque features, stenosis assessment, and quantification of calcifications (calcium scoring). FEops HEARTguideTM offers predictive simulation technology for device-anatomy interaction, AI-based anatomical measurements from CT scans, and segmentation of cardiovascular structures.

What kind of data input is required for each tool?

Salix Coronary Plaque requires CCTA scans for its analysis of coronary artery plaque and stenosis. FEops HEARTguideTM utilizes CT scans for its AI-based anatomical measurements and predictive simulations for structural heart procedure planning.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform

AISAP Cardio vs Rapid Enterprise Platform

AngioWaveNet vs Rapid Enterprise Platform

CorVista System with PH Add-On vs Rapid Enterprise Platform